Catalyst Wire Dossier Catalyst Wire Dossier

MLN6907

· Millennium Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MLN6907, covering 2017-01-05 to 2017-01-05. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Study of MLN6907 in Patients With Metastatic Colorectal [Phase 1]

See pricing